Drugs / CD64 CAR T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07347418 | Jun 2026 → Jun 2029 expected | acute myeloid leukemia, myelodysplastic syndrome | University of Colorado, Denver | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD64 CAR T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07347418 ↗ |
| Modality | Cell therapy | “lentivirally transduced autologous T cells expressing anti-CD64 chimeric antigen receptors (CAR)” NCT07347418 ↗ |